Trans and gender diverse and intersex people are still disproportionately affected by HIV worldwide; however, our access to information, to resources and to decision-making continues to be extremely limited. GATE engages in the international HIV response by challenging this historic exclusion and creating new opportunities for meaningful participation.
We do this through:
- Engaging with international HIV decision-making mechanisms.
- Facilitating trans, gender diverse and intersex activists’ participation in key events (e.g., International AIDS Conferences).
- Partnering with key population networks (e.g., IRGT, NSWP, MPACT, INPUD).
- Training donors, allies, official institutions and other stakeholders on trans, gender diverse and intersex issues.
- Organizing and facilitating meetings, trainings and working groups. to empower trans activists, networks and organizations to advocate for their inclusion in the HIV response at regional, national and global levels.
- Advocating for the diversification of trans identities in the International HIV response.
- Advocating for disaggregated data collection and analysis.
GATE is implementing a global project on trans men and HIV, focused on strengthening and generating knowledge to further their engagement in the international HIV response. Currently, there is very little awareness or inclusion of trans men in HIV platforms and this community is mostly ignored in HIV research data, all of which GATE intends to address with this new project.
This year we commemorate World AIDS Day in the shadow of the COVID-19 pandemic. Despite the devastation caused by the ongoing pandemic, we call on global policymakers and donors to not lose sight of their goal to end the HIV epidemic, which is entering its fifth decade and continues to disproportionately devastate our communities.Read more
Modern antiretroviral therapy (ART) has improved the lives of people living with HIV (PLHIV) but currently requires daily adherence. We assessed prevalence and correlates of suboptimal adherence, and measured associations with self-reported health outcomes. Data were from web-based surveys of confirmed HIV+ adults on antiretroviral treatment within 25 countries during 2019Read more
You can support our work in HIV online today.